Prior Authorization for High-Dose Opioids Effectively Reduces Daily Opioid Dose
Policies requiring prior authorization for high-dose opioid prescriptions were found to be effective in reducing the average daily opioid dose consumed.
Policy
ACA Coverage Substantial, but Did Not Impact Labor Markets
Millions of workers gained insurance coverage under the Affordable Care Act (ACA) without adverse effects on labor markets.
Patient, Consumer Groups Push for Injunction Against Short-Term Insurance Rule
The American Heart Association and others are urging the court to reconsider changes to short-term limited-duration insurance plans.
Examining the Issues Leading to Market Withdrawal of the Zecuity Patch
According to an article published in Headache, the US Food and Drug Administration (FDA) was aware of safety issues associated with the Zecuity transdermal patch for migraine prior to its approval.
FDA Launches MyStudies Mobile App in Effort to Increase Access to Real World Patient Data
The FDA has launched the MyStudies App, a mobile application aimed at supporting the collection of “real world” data and evidence for medical use.
FDA: “Disturbingly” High Levels of Heavy Metals Found in Kratom Products
The Agency conducted testing on 26 separate kratom products which revealed levels of nickel and lead considered not safe for human consumption.
Multisector Goal Alignment May Curb Medicare Expenditures
Medicare costs may be contained by incentivizing multisector health activities, according to researchers.
FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems
The announcement comes in the wake of results from the 2018 National Youth Tobacco Survey which showed a 78% increase in current e-cigarette use among high school students from 2017 to 2018.
FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds
Reports of pump failure, dosing errors, as well as other possible safety issues have prompted the Agency to issue the alert to make prescribers aware of the dangers associated with using medications not approved for intrathecal use.
How Employer-Sponsored Wellness Programs Create Ethical Dilemma for Physicians
Employer-sponsored wellness programs can put physicians in an unenviable position.
Next post in Regulatory Issues
